Blog Category

Blog Category

Press Release Category

Press Release Category

News Category

News Category

CAESAREA, Israel and TAMPA, Fla. and HANGZHOU, China, March 2, 2017 /PRNewswire/ -- Keystone Heart Ltd., a medical device company focused on developing cerebral embolic protection devices for patients undergoing cardiac procedures, and Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced a partnership agreement to provide Venus...

New third-generation cerebral embolic protection device offers improvements to further guard the brain from emboli during heart procedures including TAVRCAESAREA, Israel, and TAMPA, Florida — August 1st, 2017 —  Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients...

CAESAREA, Israel and TAMPA, Fla., Aug. 1, 2017 /PRNewswire/ -- Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac procedures, today announced plans to initiate clinical trials for a new, advanced version of Keystone Heart TriGuard™ cerebral embolic protection device.  This third-generation...

Ankündigung geht Veröffentlichung neuer Leitlinien voraus, die auf notwendige zerebrale Protektion bei TAVR verweisen CAESAREA, Israel, und TAMPA, Florida, und HANGZHOU, China, 2. März 2017 /PRNewswire/ -- Keystone Heart Ltd., ein Medizinprodukteunternehmen, das auf die Entwicklung von Hirnembolie-Schutzsystemen für Herzeingriffe spezialisiert ist, und Venus Medtech (Hangzhou) Inc., der führende...

Keystone Heart and Venus MedTech Announce Partnership for Cerebral Embolic Protection with Transcatheter Heart Valve Systems (TAVR) in China and Key Asian Markets This First Comes on Heels of New Published Guidelines Pointing To Need for Cerebral Protection During TAVR CAESAREA, Israel, TAMPA, Florida and HANGZHOU, China, — March 2, 2017— Keystone...

Skip to content